Literature DB >> 2209887

Consequences of high ovarian response to gonadotropins: a cytogenetic analysis of unfertilized human oocytes.

J J Tarín1, A Pellicer.   

Abstract

Several reports have shown decreased fertilization and implantation rates in high-responder patients to gonadotropins. In this cytogenetic study of unfertilized human oocytes, we have investigated possible reasons for this clinical evidence. Three groups of patients were established according to the number of oocytes retrieved: group 1 (n = 21), 1 to 5 oocytes; group 2 (n = 32), 6 to 10 oocytes; and group 3 (n = 35), greater than or equal to 11 oocytes. Patients in group 3 had lower estradiol levels per follicle developed, lower follicular volume, higher incidence of diploid oocytes, and higher rate of oocytes with an additional set of prematurely condensed sperm chromosomes of the presynthetic gap than groups 1 and 2. These results suggest that women with greater than or equal to 11 oocytes retrieved have a relative higher cytoplasmic immaturity that could explain the lower fertilization and implantation rates found in other studies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2209887

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  16 in total

1.  Prediction of nuclear maturity from cumulus-coronal morphology: influence of embryologist experience.

Authors:  D G Hammitt; C H Syrop; B J Van Voorhis; D L Walker; T M Miller; K M Barud; C C Hood
Journal:  J Assist Reprod Genet       Date:  1992-10       Impact factor: 3.412

2.  Cumulative exposure to high estradiol levels during the follicular phase of IVF cycles negatively affects implantation.

Authors:  Murat Arslan; Silvina Bocca; Ebru Ozturk Arslan; Hakan E Duran; Laurel Stadtmauer; Sergio Oehninger
Journal:  J Assist Reprod Genet       Date:  2007-02-16       Impact factor: 3.412

3.  Fertilization, embryo quality, and cryosurvival in in vitro fertilization and intracytoplasmic sperm injection cycles.

Authors:  J M Moilanen; M Tulppala; I Reima; O Hovatta
Journal:  J Assist Reprod Genet       Date:  1999-01       Impact factor: 3.412

Review 4.  Clinical utility of adjuvant growth hormone in the treatment of patients with polycystic ovaries undergoing in vitro fertilization.

Authors:  P G Artini; A A de Micheroux; F Taponeco; V Cela; G D'Ambrogio; A R Genazzani
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

Review 5.  Treatment of polycystic ovary patients undergoing IVF.

Authors:  P N Barri; B Coroleu; F Martinez; J M Traver; A Veiga; G Calderon
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

6.  Characterization and prediction of IVF cycles generating "slow-cleaving" embryos.

Authors:  J J Tarin; J L Romero; F Bonilla-Musoles
Journal:  J Assist Reprod Genet       Date:  1994-10       Impact factor: 3.412

7.  Chromosomal analysis of unfertilized human oocytes prepared by a gradual fixation-air drying method.

Authors:  Y Kamiguchi; B Rosenbusch; K Sterzik; K Mikamo
Journal:  Hum Genet       Date:  1993-01       Impact factor: 4.132

8.  Cycle characteristics and outcome in relation to ovarian response during in vitro fertilization.

Authors:  M R Fluker; C K Siu; J Gunby; S Daya
Journal:  J Assist Reprod Genet       Date:  1993-11       Impact factor: 3.412

9.  Comprehensive assessment of serum estradiol impact on selected physiologic markers observed during in-vitro fertilization and embryo transfer cycles.

Authors:  Grace Wing Shan Kong; Lai Ping Cheung; Christopher John Haines; Po Mui Lam
Journal:  J Exp Clin Assist Reprod       Date:  2009-10-20

10.  The impact of supraphysiologic serum estradiol levels on peri-implantation embryo development and early pregnancy outcome following in vitro fertilization cycles.

Authors:  Anthony N Imudia; Randi H Goldman; Awoniyi O Awonuga; Diane L Wright; Aaron K Styer; Thomas L Toth
Journal:  J Assist Reprod Genet       Date:  2013-11-06       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.